top of page
Newsroom Latest News
Newsroom: Latest News
Studies Suggest Sperm Counts Have Declined 50% in the Last 50 Years; New Innovation May Help Address Male Infertility
JUN04
2024
IGYXOS Initiates Phase 1 Clinical Trials for IGX12: A Breakthrough Treatment for Infertility
NOV16
2023
24
Emmanuel Dulac Appointed as new CEO of Igyxos
JUN20
2023
22
Igyxos selected for the French Tech 120 (FT120) program for the third consecutive year
APR25
2022
21
Igyxos pursues its development and appoints Thierry Ziegler as CMC Chief Operating Officer
MAR15
2021
20
Igyxos and Selexis enter service agreement to advance Igyxos’ first-in-class monoclonal antibody for the treatment of human infertility
SEP02
2020
Newsroom Latest News
Newsroom: Latest News
IGYXOS Initiates Phase 1 Clinical Trials for IGX12: A Breakthrough Treatment for Infertility
NOV16
2023
24
Emmanuel Dulac Appointed as new CEO of Igyxos
JUN20
2023
22
Igyxos selected for the French Tech 120 (FT120) program for the third consecutive year
APR25
2022
21
Igyxos pursues its development and appoints Thierry Ziegler as CMC Chief Operating Officer
MAR15
2021
20
Igyxos and Selexis enter service agreement to advance Igyxos’ first-in-class monoclonal antibody for the treatment of human infertility
SEP02
2020
bottom of page